跳至主要内容
临床试验/NCT04436848
NCT04436848Unknown不适用

Identifying Leucocyte and Urine Biomarkers in Parkinson's Patients With LRRK2 G2385R Gene Variant

University of Malaya1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2020年6月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
150
试验地点
1
主要终点
Identification of monocyte-based biomarkers for LRRK2 G2385R variant

研究概览

简要总结

Given the emerging evidence on LRRK2-related biomarkers, this project will focus on identifying leucocyte and urine biomarkers that are altered by the LRRK2 G2385R variant, and investigating the effects of LRRK2 kinase inhibitor (MLi-2) on these biomarkers, using immunoblotting and mass spectrometry.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of Parkinson's disease assigned by a movement disorder specialist according to clinical diagnostic criteria
  • Age above 18 year-old
  • Provision of a written informed consent

排除标准

  • Physical or mental incapacity to complete study protocol

结局指标

主要结局

Identification of monocyte-based biomarkers for LRRK2 G2385R variant

时间窗: Two years

Identification of urine-based biomarkers for LRRK2 G2385R variant

时间窗: Two years

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验